Search company, investor...
Avvo company logo


Founded Year



Acquired | Acquired

Total Raised


About Avvo is the web's largest legal marketplace for consumers and attorneys. In Avvo's Q&A forum, consumers can get free legal advice 24/7 from more than 160,000 participating lawyers, and Avvo's directory provides comprehensive profiles, client reviews, peer endorsements and the industry-recognized Avvo Rating for more than 97 percent of all lawyers in the U.S. Avvo also helps lawyers grow their business with Avvo Ignite, a cloud-based marketing platform and website solution designed specifically for attorneys.

Headquarters Location

720 Olive Way Suite 1400

Seattle, Washington, 98101,

United States


Missing: Avvo's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Avvo's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Avvo News

The Law Offices of Timothy L. Miles Informs Investors of a Class Action Lawsuit Against Y-mAbs Therapeutics, Inc.

Jan 21, 2023

. News Provided By Share This Article Nationally Recognized Class Attorney Timothy L. MIles Awarded AV Preeminent Award for Tenth Straight Year Timothy L. Miles, a nationally recognized shareholder rights attorney Nationally Recognized Class Action Attorney Timothy L. Miles Selected as a Top Rated Lawyer in Tennessee for the Third Straight Year Timothy L. Miles, a nationally recognized shareholder rights attorney Class action lawsuit charges Y-mAbs and certain of its top executive officers with violations of the Securities Exchange Act of 1934 Y-mAbs Therapeutics, Inc. (NASDAQ:Y-mAbs) — Timothy L. Miles NASHVILLE, TENNESSEE, UNITED STATES, January 21, 2023 / / -- The Law Offices of Timothy L. Miles , who has been leading the fight to protect shareholder rights for over 20 years, informs investors that a that a purchaser of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB), who suffered losses inY-mAbs stock, filed a class action complaint against the Company for violations of the securities laws. The Y-mAbs class action lawsuit seeks to represent purchasers of Y-mAbs common stock on the open market, or pursuant to Registration Statements filed with the U.S. Securities and Exchange Commission (“SEC”), between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”). 23-cv-00431 (S.D.N.Y. ), the Y-mAbs class action lawsuit charges Y-mAbs and certain of its top executives with violations of the Securities Exchange Act of 1934. If you suffered losses in Y-mAbs ​ and wish to serve as lead plaintiff of the Y-mAbs class action lawsuit, or just have questions as an investor, please visit us here . You can also contact Y-mAbs Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at Lead plaintiff motions for the Y-mAbs class action lawsuit must be filed with the court no later than March 20, 2023. If you suffered losses in Y-mAbs and have questions, please contact Y-mAbs Stock Loss Lawyer Timothy L. Miles today. Allegations in the Y-mAbs Class Action Lawsuit Y-mAbs is a biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Specifically, Y-mAbs is developing Omburtamab, which is being studied for the treatment of neuroblastoma in the central nervous system or leptomeninges of pediatric patients. The Y-mAbs class action lawsuit alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Y-mAbs misrepresented the U.S. Food and Drug Administration’s (“FDA”) willingness to approve Omburtamab for marketing based on the existing clinical trials; (ii) Y-mAbs misrepresented that progress was being made that would align with the FDA’s requirements to demonstrate substantial evidence of effectiveness, sufficient for approval of Omburtamab, through adequate and well-controlled studies; and (iii) the FDA had repeatedly advised Y-mAbs that it was unlikely to grant approval for the marketing of Omburtamab. On October 26, 2022, the FDA published its briefing documents for an October 28, 2022 Advisory Committee (“AdCom”) Meeting, which identified key issues with Y-mAbs’ Omburtamab application. On this news, Y-mAbs’ stock price declined by more than 27%. Then, on October 28, 2022, Y-mAbs revealed to investors that the AdCom had voted 16 to 0 to deny the application and that Y-mAbs had not provided sufficient evidence to conclude that Omburtamab improved overall survival. On this news, Y-mAbs’ stock price declined nearly 60%, further damaging investors. Y-mAbs Shareholders Urged to Contact the Firm If you purchased Y-mAbsr securities or have any questions concerning this announcement or your rights or interests with respect to these matters, please click here for more information or contact Timothy L. Miles, Esquire, Toll-Free at 855-846-6529, or by email to If you inquire by email please include your mailing address, telephone number, and the number shares owned. About Timothy L. Miles Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer and a 2022 Top Rated Litigator. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Awards: Top Rated Litigator by Martindale-Hubbell® and ALM (2019); 2019 Elite Lawyer of The South by Martindale-Hubbell® and ALM (2019); Member of the Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association (2017-2019); AV® Preeminent™ Rating by Martindale-Hubble® (2014-2020); PRR AV Preeminent Rating on (2017 & 2019); The Top-Rated Lawyer in Litigation™ for Ethical Standards and Legal Ability (Martindale-Hubble® 2015); Lifetime Achievement Award by Premier Lawyers of America (2019); Superb Rated Attorney (Avvo); Avvo Top Rated Lawyer for (Avvo 2017-2020). Mr. Miles has authored numerous publications advocating for shareholdings including most recently: Free Portfolio Monitoring Services Offered by Plaintiff Securities Firms Provides Significant Benefits To Investors (Timothy L. Miles, Dec. 3, 2019). Contact:

Avvo Frequently Asked Questions (FAQ)

  • When was Avvo founded?

    Avvo was founded in 2006.

  • Where is Avvo's headquarters?

    Avvo's headquarters is located at 720 Olive Way, Seattle.

  • What is Avvo's latest funding round?

    Avvo's latest funding round is Acquired.

  • How much did Avvo raise?

    Avvo raised a total of $132M.

  • Who are the investors of Avvo?

    Investors of Avvo include Internet Brands, Coatue Management, Cercano Management, Technology Crossover Ventures, Benchmark and 4 more.

  • Who are Avvo's competitors?

    Competitors of Avvo include LegalZoom and 8 more.

Compare Avvo to Competitors

UpCounsel Logo

UpCounsel is an interactive online service that helps businesses find and hire legal help based on their preferences. By combining price transparency, reviews, and online tools, the company's platform allows users to tap into a legal workforce that can meet business needs on schedule.

LawKick Logo

LawKick makes it easier than ever to find legal help that meets your needs and budget. You simply answer some questions about your legal needs and receive personalized price quotes from qualified lawyers nearby. The average project receives a response in under 18 minutes and the cost varies an average of $1849 between the lowest and highest bids. We are saving people significant time and money in the process of seeking legal help. Why It Works: Our platform allows users to quickly consult with multiple attorneys from a single, centralized platform, making it easy and efficient to hire the right lawyer for their specific situation. All attorneys are pre-vetted and screened for quality by our team prior to signing up. LawKick saves attorneys time and money by streamlining new client consultations and providing an efficient, targeted client acquisition channel to reduce marketing expenses. We are bringing the $300B legal marketplace online to create efficiency and transparency.

Lawdingo Logo

Lawdingo is a marketplace for securing the time and attention of legal professionals. The company allows users to connect virtually and pay legal fees by the minute online. Lawdingo allows people to connect via video conference, telephone or text for legal consultations.

Legal Hero Logo
Legal Hero

Legal Hero changes the way that small businesses identify and retain lawyers, bringing up-front (and mostly fixed) pricing, transparency and efficiency to the industry. The company offers a closely-managed network of lawyers to small businesses under one brand, providing a high-quality and streamlined experience to users.

AttorneyFee Logo

AttorneyFee is like Mint for legal services. We help people find attorneys that fit within their budget and manage their legal expenses.

Rocket Lawyer Logo
Rocket Lawyer

Rocket Lawyer allows users to create customized legal documents that can be downloaded and shared instantly. Legal plan members have access to free document reviews from local attorneys and receive discounted rates on legal services for more complicated legal needs. Lawyers can access easy online marketing tools and targeted client referrals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.